加强阿片类药物识别和并发障碍算法的验证
概括
这项研究验证了用于识别与阿片类药物使用,过量服用,物质使用障碍和心理健康问题相关的医院遭遇的算法. 算法性能各不相同,阿片类药物参与显示了最高的准确性,突出显示了未来分析的数据完整性需求.
科学领域:
- 医疗信息学 医疗信息学
- 公共卫生研究 公共卫生研究
- 在医疗保健中的数据科学.
背景情况:
- 准确识别特定健康状况的医院接触对于公共卫生监测和资源分配至关重要.
- 现有的算法经常结合医疗代码和自然语言处理 (NLP) 以提高准确性.
- 2016年国家医院护理调查 (NHCS) 为评估此类算法提供了有价值的数据集.
研究的目的:
- 验证两个算法的可靠性,旨在识别与阿片类药物参与,阿片类药物过量服用,物质使用障碍和心理健康问题相关的医院遭遇.
- 用F-score和马修斯相关系数等既定指标来评估算法性能.
- 为未来的NHCS分析确定算法设计和数据收集的改进领域.
主要方法:
- 一项验证研究使用2016年NHCS的900个医院遭遇的分层样本进行.
- 医疗记录抽象由训练有素的抽象者进行,以确定阿片类药物参与,过量服用,物质使用障碍和心理健康问题的存在.
- 将算法输出与抽象器确定进行比较,以计算性能指标 (F-score,马修斯相关系数).
主要成果:
- 在目标条件和指标中,算法性能差异很大.
- 阿片类药物参与算法表现出最高的性能,F-score为0.95.
- 阿片类药物过量算法显示出最低的性能 (F值为0.48),而马修斯相关系数表明所有算法中的性能普遍较差.
- 对差异的确定的原因包括过于广泛的代码/关键字包含和不完整的调查数据.
结论:
- 验证研究确定了开发算法的优缺点,指导了未来的改进.
- 算法性能凸显了大规模医疗调查中数据完整性的关键重要性.
- 这些发现为改进未来对NHCS和类似数据集的分析提供了基础.
更多相关视频
10:13Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
Published on: November 8, 2024
2.2K
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
2.2K
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
300
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
300
Drug Abuse and Addiction: Pharmacological Phenomena
476
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
476
Analgesia and Pain Management
623
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
623
Opioid Analgesics: Morphine and Other Natural Cogeners
250
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
250
Opioid Receptors: Overview
836
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
836
Diagnostic and Statistical Manual of Mental Disorders (DSM)
56
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
56
